Demise of the Planktic Foraminifer genus Morozovella during the Early Eocene Climatic Optimum: new records from ODP Site 1258 (Demerara Rise, western equatorial Atlantic) and Site 1263 (Walvis Ridge, South Atlantic)

Here we present relative abundances of planktic foraminifera that span the Early Eocene Climatic Optimum (EECO) at Ocean Drilling Program (ODP) Site 1258 in the western equatorial Atlantic. The EECO (~53.3−49.1 Ma) represents peak Cenozoic warmth, probably related to high atmospheric CO2, and when planktic foraminifera, a dominant component of marine sediment, exhibit a major biotic response. Consistent with previous work, the relative abundance of the genus Morozovella, which dominated early Paleogene tropical-subtropical assemblages, markedly and permanently declined from a mean percentage of ~32% to less than ~7% at the beginning of the EECO. The distinct decrease in Morozovella abundance occurred at Site 1258 within ~20 kyr before a negative excursion in δ13C records known as the J event and which defines the beginning of EECO. Moreover, all morozovellid species except M. aragonensis dropped in abundance permanently at Site 1258, and this is related to a reduction in test-size. Comparing our data with that from other locations, the remarkable switch in planktonic foraminifera assemblages appears to have begun first with unfavourable environmental conditions near the Equator and then extended to higher latitudes. Several potential stressors may explain observations, including some combination of algal photosymbiont inhibition (bleaching), a sustained increase in temperature, or an extended decrease in pH

Motion sickness incidence during a round-the-world yacht race

Motion sickness experiences were obtained from participants in a 9 month, round the world yacht race. Race participants completed questionnaires on their motion sickness experience 1 week prior to the start of the race, during the race, and following the race. Yacht headings, sea states, and wind directions were recorded throughout the race. Illness and the occurrence of vomiting were related to the duration at sea and yacht encounter directions relative to the prevailing wind. Individual crewmember characteristics, the use of anti-motion sickness drugs, activity while at sea, and after-effects of yacht motion were also examined with respect to sickness occurrence, Sickness was greatest among females and younger crewmembers, and among crewmembers who used anti-motion sickness drugs. Sickness varied as a function of drug type and activity while at sea. Crewmembers who reported after-effects of yacht motion also reported greater sickness while at sea. ]he primary determinants of motion sickness were the duration of time spent at sea and yacht encounter direction to the prevailing wind. R ESEARCH HAS ESTABLISHED that seasickness is dependent on the magnitude of ship motion The majority of studies of seasickness have involved single voyages (e.g., 8) or multiple, short duration voyages (e.g., 10). There have been few investigations of the incidence of seasickness over prolonged periods at sea. Wiker et al. conducted 3-d sea trials involving different U.S. Coast Guard vessels navigating an octagonal course (16). The incidence of motion sickness was found to be greater on vessels producing greater magnitudes of vertical motion. Vomiting and lesser symptoms of motion sickness were greatest when steaming with a component of head seas. Applebee et al. Goto and Kanda (5) examined sickness data from 35 sea cadets on board a 97-m training vessel during a 4-month voyage in the Pacific Ocean. Motion sickness symptoms decreased logarithmically as days at sea increased, the incidence of motion sickness falling to 10% of its original value over the first 10 d at sea. The authors suggest that motion sickness incidence can be determined from two factors: a h u m a n response factor derived from the magnitude of vertical acceleration experienced, and an exposure effect function based on the decline in sickness incidence with days spent at sea. It is clear that motion sickness during extended periods at sea is not simply determined by the sea conditions. Motion sickness incidence will also be determined by the type of vessel, the vessel heading and the prevailing sea and wind conditions (encounter direction) and the period of time spent at sea. Predictions of seasickness incidence based only on short duration exposures do not allow for the effect of habituation. Initial susceptibility to motion sickness and the rate of habituation m a y differ from person to person depending on age, gender, previous sailing experience, and the use of anti-motion sickness drugs (e.g., 13). This study investigated the importance of sea state, vessel encounter direction and continuous exposure duration as determinants of motion sickness over prolonged periods at sea during the 1992-93 British Steel Challenge ocean yacht race. The effects of individual characteristics and individual behavior on the incidence of motion sickness were also examined. M E T H O D S The British Steel Challenge: T h e British Steel Challenge was a 9-month, 28,000 mile yacht race involving a cirFrom the Huma

Estimating the number needed to treat from continuous outcomes in randomised controlled trials: methodological challenges and worked example using data from the UK Back Pain Exercise and Manipulation (BEAM) trial

Background Reporting numbers needed to treat (NNT) improves interpretability of trial results. It is unusual that continuous outcomes are converted to numbers of individual responders to treatment (i.e., those who reach a particular threshold of change); and deteriorations prevented are only rarely considered. We consider how numbers needed to treat can be derived from continuous outcomes; illustrated with a worked example showing the methods and challenges. Methods We used data from the UK BEAM trial (n = 1, 334) of physical treatments for back pain; originally reported as showing, at best, small to moderate benefits. Participants were randomised to receive 'best care' in general practice, the comparator treatment, or one of three manual and/or exercise treatments: 'best care' plus manipulation, exercise, or manipulation followed by exercise. We used established consensus thresholds for improvement in Roland-Morris disability questionnaire scores at three and twelve months to derive NNTs for improvements and for benefits (improvements gained+deteriorations prevented). Results At three months, NNT estimates ranged from 5.1 (95% CI 3.4 to 10.7) to 9.0 (5.0 to 45.5) for exercise, 5.0 (3.4 to 9.8) to 5.4 (3.8 to 9.9) for manipulation, and 3.3 (2.5 to 4.9) to 4.8 (3.5 to 7.8) for manipulation followed by exercise. Corresponding between-group mean differences in the Roland-Morris disability questionnaire were 1.6 (0.8 to 2.3), 1.4 (0.6 to 2.1), and 1.9 (1.2 to 2.6) points. Conclusion In contrast to small mean differences originally reported, NNTs were small and could be attractive to clinicians, patients, and purchasers. NNTs can aid the interpretation of results of trials using continuous outcomes. Where possible, these should be reported alongside mean differences. Challenges remain in calculating NNTs for some continuous outcomes

Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.

BACKGROUND: Blood transcriptional signatures are candidates for non-sputum triage or confirmatory tests of tuberculosis. Prospective head-to-head comparisons of their diagnostic accuracy in real-world settings are necessary to assess their clinical use. We aimed to compare the diagnostic accuracy of candidate transcriptional signatures identified by systematic review, in a setting with a high burden of tuberculosis and HIV. METHODS: We did a prospective observational study nested within a diagnostic accuracy study of sputum Xpert MTB/RIF (Xpert) and Xpert MTB/RIF Ultra (Ultra) tests for pulmonary tuberculosis. We recruited consecutive symptomatic adults aged 18 years or older self-presenting to a tuberculosis clinic in Cape Town, South Africa. Participants provided blood for RNA sequencing, and sputum samples for liquid culture and molecular testing using Xpert and Ultra. We assessed the diagnostic accuracy of candidate blood transcriptional signatures for active tuberculosis (including those intended to distinguish active tuberculosis from other diseases) identified by systematic review, compared with culture or Xpert MTB/RIF positivity as the standard reference. In our primary analysis, patients with tuberculosis were defined as those with either a positive liquid culture or Xpert result. Patients with missing blood RNA or sputum results were excluded. Our primary objective was to benchmark the diagnostic accuracy of candidate transcriptional signatures against the WHO target product profile (TPP) for a tuberculosis triage test. FINDINGS: Between Feb 12, 2016, and July 18, 2017, we obtained paired sputum and RNA sequencing data from 181 participants, 54 (30%) of whom had confirmed pulmonary tuberculosis. Of 27 eligible signatures identified by systematic review, four achieved the highest diagnostic accuracy with similar area under the receiver operating characteristic curves (Sweeney3: 90·6% [95% CI 85·6-95·6]; Kaforou25: 86·9% [80·9-92·9]; Roe3: 86·9% [80·3-93·5]; and BATF2: 86·8% [80·6-93·1]), independent of age, sex, HIV status, previous tuberculosis, or sputum smear result. At test thresholds that gave 70% specificity (the minimum WHO TPP specificity for a triage test), these four signatures achieved sensitivities between 83·3% (95% CI 71·3-91·0) and 90·7% (80·1-96·0). No signature met the optimum criteria, of 95% sensitivity and 80% specificity proposed by WHO for a triage test, or the minimum criteria (of 65% sensitivity and 98% specificity) for a confirmatory test, but all four correctly identified Ultra-positive, culture-negative patients. INTERPRETATION: Selected blood transcriptional signatures met the minimum WHO benchmarks for a tuberculosis triage test but not for a confirmatory test. Further development of the signatures is warranted to investigate their possible effects on clinical and health economic outcomes as part of a triage strategy, or when used as add-on confirmatory test in conjunction with the highly sensitive Ultra test for Mycobacterium tuberculosis DNA. FUNDING: Royal Society Newton Advanced Fellowship, Wellcome Trust, National Institute of Health Research, and UK Medical Research Council

The Effects Of N, P And Crude Oil On The Decomposition Of Spartina Alterniflora Belowground Biomass

We conducted a laboratory experiment to examine how the decomposition of particulate belowground organic matter from a salt marsh is enhanced, or not, by different mixtures of crude oil, nitrogen (N), or phosphorus (P) acting individually or synergistically. The experiment was conducted in 3.8 L sampling chambers producing varying quantities of gas whose volume was used as a surrogate measure of organic decomposition under anaerobic conditions. Gas production after 28 days, from highest to lowest, was +NP = +N \u3e\u3e\u3e +P, or +oil. The gas production under either +P or +oil conditions was indistinguishable from gas production in the control chamber. Nitrogen, not phosphorus, or +NP, was the dominant factor controlling organic decomposition rates in these experiments. The implication for organic salt marsh soils is that shoreline erosion is enhanced by salt marsh oiling, presumably by its toxicity, but not by its effect on the decomposition rates of plant biomass belowground. Nutrient additions, on the other hand, may compromise the soil strength, creating a stronger disparity in soil strength between upper and lower soil layers leading to marsh loss. Nutrient amendments intended to decrease oil concentration in the marsh may not have the desired effect, and are likely to decrease soil strength, thereby enhancing marsh-to-water conversions in organic salt marsh soils

Prenatal Vitamin D Supplementation and Child Respiratory Health: A Randomised Controlled Trial

PMCID: PMC3691177This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Dark Force Detection in Low Energy e-p Collisions

We study the prospects for detecting a light boson X with mass m_X < 100 MeV at a low energy electron-proton collider. We focus on the case where X dominantly decays to e+ e- as motivated by recent "dark force" models. In order to evade direct and indirect constraints, X must have small couplings to the standard model (alpha_X 10 MeV). By comparing the signal and background cross sections for the e- p e+ e- final state, we conclude that dark force detection requires an integrated luminosity of around 1 inverse attobarn, achievable with a forthcoming JLab proposal.Comment: 38 pages, 19 figures; v2, references adde